While the greater face of American healthcare has yet to be determined, the relationships between doctors and insurance companies will always be tense.
Formula Pharmaceuticals is a privately-held, clinical stage biopharmaceutical company. Its Mission is to develop drug candidates which target large markets characterized by significant unmet medical needs, while providing investors with rapid time-to-value returns.
If the National Research Universal Reactor at AECL, Ltd., located in Chalk River, Ontario, closes permanently in 2015 as it is currently scheduled to do, it will exacerbate an already severe shortage of a radioisotope critical to medical imaging known as Molybdenum-99 (Mo-99).